ID   MP57
AC   CVCL_VJ89
DR   Cosmic; 2663903
DR   Wikidata; Q95990774
RX   PubMed=27117832;
CC   Doubling time: ~24 hours (PubMed=27117832).
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Simple; p.Gly373Arg (c.1117G>C); Zygosity=Homozygous (PubMed=27117832).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro87Glnfs*36 (c.260delC); Zygosity=Homozygous (PubMed=27117832).
DI   NCIt; C7569; Thymic carcinoma
DI   ORDO; Orphanet_99868; Thymic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=27117832; DOI=10.1016/j.jtho.2016.04.013; PMCID=PMC5319212;
RA   Alberobello A.T., Wang Y.-S., Beerkens F.J., Conforti F.,
RA   McCutcheon J.N., Rao G.-H., Raffeld M., Liu J., Rahhal R., Zhang Y.-W.,
RA   Giaccone G.;
RT   "PI3K as a potential therapeutic target in thymic epithelial tumors.";
RL   J. Thorac. Oncol. 11:1345-1356(2016).
//